|
1
|
Bonnet D and Dick JE: Human acute leukemia
is organized as a hierarchy that originates from a primitive
hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cell. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
7
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Piccirillo SG, Reynolds BA, Zanetti N, et
al: Bone morphogenetic proteins inhibit the tumorigenic potential
of human brain tumour-initiating cells. Nature. 444:761–765. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishii H, Iwatsuki M, Ieta K, Ohta D,
Haraguchi N, Mimori K and Mori M: Cancer stem cells and
chemoradiation resistance. Cancer Sci. 99:1871–1877. 2008.
View Article : Google Scholar
|
|
11
|
Dewi DL, Ishii H, Kano Y, et al: Cancer
stem cell theory in gastrointestinal malignancies: recent progress
and upcoming challenges. J Gastroenterol. 46:1145–1157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haraguchi N, Ishii H, Mimori K, et al:
CD13 is a therapeutic target in human liver cancer stem cells. J
Clin Invest. 120:3326–3339. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tamada M, Nagano O, Tateyama S, et al:
Modulation of glucose metabolism by CD44 contributes to antioxidant
status and drug resistance in cancer cells. Cancer Res.
72:1438–1448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishimoto T, Nagano O, Yae T, et al: CD44
variant regulates redox status in cancer cells by stabilizing the
xCT subunit of system xc(−) and thereby promotes tumor growth.
Cancer Cell. 19:387–400. 2011.PubMed/NCBI
|
|
15
|
Marcato P, Dean CA, Giacomantonio CA and
Lee PW: Aldehyde dehydrogenase: its role as a cancer stem cell
marker comes down to the specific isoform. Cell Cycle.
10:1378–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ginestier C, Hur MH, Charafe-Jauffret E,
et al: ALDH1 is a marker of normal and malignant human mammary stem
cells and a predictor of poor clinical outcome. Cell Stem Cell.
1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feldmann G, Dhara S, Fendrich V, et al:
Blockade of hedgehog signaling inhibits pancreatic cancer invasion
and metastases: a new paradigm for combination therapy in solid
cancers. Cancer Res. 67:2187–2196. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma S, Chan KW, Lee TK, Tang KH, Wo JY,
Zheng BJ and Guan XY: Aldehyde dehydrogenase discriminates the
CD133 liver cancer stem cell populations. Mol Cancer Res.
6:1146–1153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang EH, Hynes MJ, Zhang T, et al:
Aldehyde dehydrogenase 1 is a marker for normal and malignant human
colonic stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Todaro M, Iovino F, Eterno V, et al:
Tumorigenic and metastatic activity of human thyroid cancer stem
cells. Cancer Res. 70:8874–8885. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sullivan JP, Spinola M, Dodge M, et al:
Aldehyde dehydrogenase activity selects for lung adenocarcinoma
stem cells dependent on notch signaling. Cancer Res. 70:9937–9948.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma I and Allan AL: The role of human
aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell
Rev. 7:292–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wakamatsu Y, Sakamoto N, Oo HZ, et al:
Expression of cancer stem cell markers ALDH1, CD44 and CD133 in
primary tumor and lymph node metastasis of gastric cancer. Pathol
Int. 62:112–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takaishi S, Okumura T, Tu S, et al:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cell. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Han ME, Jeon TY, Hwang SH, et al: Cancer
spheres from gastric cancer patients provide an ideal model system
for cancer stem cell research. Cell Mol Life Sci. 68:3589–3605.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen T, Yang K, Yu J, et al:
Identification and expansion of cancer stem cells in tumor tissues
and peripheral blood derived from gastric adenocarcinoma patients.
Cell Res. 22:248–258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fukuda K, Saikawa Y, Ohashi M, et al:
Tumor initiating potential of side population cells in human
gastric cancer. Int J Oncol. 34:1201–1207. 2009.PubMed/NCBI
|
|
28
|
Jiang J, Zhang Y, Chuai S, et al:
Trastuzumab (herceptin) targets gastric cancer stem cells
characterized by CD90 phenotype. Oncogene. 31:671–682. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katsuno Y, Ehata S, Yashiro M, Yanagihara
K, Hirakawa K and Miyazono K: Coordinated expression of REG4 and
aldehyde dehydrogenase 1 regulating tumourigenic capacity of
diffuse-type gastric carcinoma-initiating cells is inhibited by
TGF-β. J Pathol. 228:391–404. 2012.PubMed/NCBI
|
|
30
|
Marshall BJ and Warren JR: Unidentified
curved bacilli in the stomach of patients with gastritis and peptic
ulceration. Lancet. 16:1311–1315. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Suganuma M, Yamaguchi K, Ono Y, et al:
TNF-alpha-inducing protein, a carcinogenic factor secreted from
H. pylori, enters gastric cancer cells. Int J Cancer.
123:117–122. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sinkovics JG: Molecular biology of
oncogenic inflammatory processes. I. Non-oncogenic and oncogenic
pathogens, intrinsic inflammatory reactions without pathogens and
microRNA/DNA interactions (Review). Int J Oncol. 40:305–349.
2012.
|
|
33
|
Bhattacharyya A, Chattopadhyay R, Hall EH,
Mebrahtu ST, Ernst PB and Crowe SE: Mechanism of hypoxia-inducible
factor 1 alpha-mediated Mcl1 regulation in Helicobacter
pylori-infected human gastric epithelium. Am J Physiol
Gastrointest Liver Physiol. 299:G1177–G1186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Barker HE, Cox TR and Erler JT: The
rationale for targeting the LOX family in cancer. Nat Rev Cancer.
12:540–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
